Vietnamese health authorities are urging pregnant women to discuss RSV immunization with their doctors as data confirms infants under three months face the highest risk of severe hospitalization.
A meta-analysis of 61 studies across 19 countries found hospitalization rates peak in the first three months of life and decline with age, vietnam.vn reported. In Vietnam, the National Children’s Hospital recorded that 42.7 percent of RSV-related bronchiolitis admissions involved infants under three months, while Children’s Hospital 1 in Ho Chi Minh City estimated the same age group accounts for roughly 25 percent of severe pediatric RSV cases.
“RSV is one of the most common causes of bronchiolitis and pneumonia in infants and young children,” said Dr. Phan Huu Phuc, Deputy Director of the National Children’s Hospital and General Secretary of the Vietnam Pediatric Association. He told vietnam.vn that infants under three months can develop severe lower respiratory tract infections requiring respiratory support and hospitalization, making early monitoring critical.
The virus circulates year-round in northern Vietnam with a surge typically from October to March, while southern Vietnam sees peaks during the rainy season from May to November. No routine antiviral treatment exists; care focuses on symptom management, hydration, and respiratory support, with severe cases requiring intensive care or ECMO.
Maternal vaccination, administered as a single dose between 24 and 36 weeks of gestation, aims to transfer protective antibodies across the placenta. Dr. Nguyen Duc Hau of the Long Chau Vaccination System told vietnam.vn the vaccine stimulates the mother’s immune system to produce antibodies that pass to the fetus, providing passive protection during the vulnerable early months. He emphasized pregnant women should complete vaccination at least two weeks before their due date and consult a physician on timing based on gestational age, health history, and local RSV seasonality.
CDC guidelines recommend vaccination between 32 and 36 weeks, depending on local epidemiology. In some countries, long-acting monoclonal antibodies are offered to infants as an alternative; CDC guidance states most infants need only one of the two interventions.
Dr. Nguyen Duc Hau noted the choice depends on clinical indications, product availability, and national guidelines.
Families are advised to maintain hygiene, avoid contact with sick individuals, ensure ventilation, and eliminate smoke exposure. Warning signs — chest retractions, worsening breathlessness, cyanosis, apnea, feeding refusal, or unusual lethargy — warrant immediate medical attention.
Related reading
- Nike and Science in Sport Announce Multi-Year Nutrition Partnership, Products Launch Spring 2027
- Maternal and Fetal Outcomes of Preeclampsia in South Asia: A Systematic Review
- Rangers’ Oliver Bjorkstrand, Alberts Šmits out 2-3 months; Luke Glendening to go on waivers (newsylist.com)
- History Shows That Deep National Crises in the Netherlands Only Begin to Clear (archyde.com)